Sugimoto Toshitsugu, Sato Masayo, Dehle Francis C, Brnabic Alan J M, Weston Adele, Burge Russel
Shimane University Faculty of Medicine, Internal Medicine 1, Shimane, Japan.
Eli Lilly Japan K.K., Lilly Research Laboratories, Kobe, Japan.
Value Health Reg Issues. 2016 May;9:49-56. doi: 10.1016/j.vhri.2015.09.005. Epub 2015 Dec 4.
The prevalence of both lifestyle-related metabolic disorders and osteoporosis is increasing in Asia.
To conduct a systematic review of the published literature to identify studies examining disorders of glucose and lipid metabolism (type 2 diabetes, hyperglycemia, hypercholesterolemia, hyperlipidemia, dyslipidemia, metabolic syndrome [MetS], and atherosclerosis) as risk factors for osteoporosis and fracture in Asian populations. Studies examining the relationship between metabolic disorders and bone mineral density (BMD) were also included.
EMBASE (including MEDLINE) and the Cochrane Library were searched. Studies conducted only within Asia, which reported multivariate analysis with a sample size of 200 or more subjects, were included.
A total of 32 studies were included. All six studies examining diabetes and fracture found that subjects with diabetes had a significantly higher risk of fracture than did subjects without diabetes (risk estimate range 1.26-4.73). Two studies found that subjects with atherosclerosis had a significantly higher risk of fracture (risk estimate range 1.10-2.52). Studies consistently reported that MetS is likely associated with osteoporosis or decreased BMD in men but not women. No consistent association was found for diabetes and BMD, with studies reporting contrasting results. There was limited evidence investigating lipid metabolism and hyperglycemia and risk of fracture or bone loss in Asian populations.
These findings suggest that diabetes is a risk factor for fracture in Asian populations. MetS may be associated with bone loss in Asian men and atherosclerosis associated with increased fractures; however, caution is needed interpreting these findings given limitations in study design.
在亚洲,与生活方式相关的代谢紊乱和骨质疏松症的患病率都在上升。
对已发表的文献进行系统综述,以确定有关葡萄糖和脂质代谢紊乱(2型糖尿病、高血糖、高胆固醇血症、高脂血症、血脂异常、代谢综合征[MetS]和动脉粥样硬化)作为亚洲人群骨质疏松症和骨折危险因素的研究。还纳入了研究代谢紊乱与骨密度(BMD)之间关系的研究。
检索了EMBASE(包括MEDLINE)和Cochrane图书馆。纳入仅在亚洲进行的、报告了样本量为200或更多受试者的多变量分析的研究。
共纳入32项研究。所有六项研究糖尿病与骨折的研究均发现,糖尿病患者骨折风险显著高于非糖尿病患者(风险估计范围为1.26 - 4.73)。两项研究发现,动脉粥样硬化患者骨折风险显著更高(风险估计范围为1.10 - 2.52)。研究一致报告,MetS可能与男性骨质疏松症或骨密度降低有关,而与女性无关。关于糖尿病与骨密度,未发现一致的关联,各项研究报告的结果相互矛盾。在亚洲人群中,研究脂质代谢和高血糖与骨折或骨质流失风险之间关系的证据有限。
这些发现表明,糖尿病是亚洲人群骨折的危险因素。MetS可能与亚洲男性骨质流失有关,动脉粥样硬化与骨折增加有关;然而,鉴于研究设计的局限性,在解释这些发现时需要谨慎。